Friday, September 25, 2015

Blood Cancer Journal - Table of Contents alert Volume 5 September 2015

If you are unable to see the message below, click here to view.
Blood Cancer Journal

TABLE OF CONTENTS

Volume 5, September 2015

In this issue
Original Articles
Letters to the Editor
Sign up for e-alerts Sign up for e-alerts
Web feed
Advertisement
Blood Cancer Journal is an online-only, open access journal publishing high quality research on hematologic malignancies and related disorders. The journal has an Impact Factor of 3.467.

In support of the Blood Cancer Awareness month, explore the latest research articles and discover the benefits of submitting your next manuscript.

Original Articles

Top

Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts

R Aliperta, M Cartellieri, A Feldmann, C Arndt, S Koristka, I Michalk, M von Bonin, A Ehninger, J Bachmann, G Ehninger, M Bornhäuser and M P Bachmann

Blood Cancer J 2015 5: e348; 10.1038/bcj.2015.73

Abstract | Full Text

Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment

D Russo, M Malagola, C Skert, V Cancelli, D Turri, P Pregno, M Bergamaschi, M Fogli, N Testoni, A De Vivo, F Castagnetti, E Pungolino, F Stagno, M Breccia, B Martino, T Intermesoli, G R Cambrin, G Nicolini, E Abruzzese, M Tiribelli, C Bigazzi, E Usala, S Russo, A Russo-Rossi, M Lunghi, M Bocchia, A D'Emilio, V Santini, M Girasoli, R Di Lorenzo, S Bernardi, A Di Palma, B M Cesana, S Soverini, G Martinelli, G Rosti and M Baccarani

Blood Cancer J 2015 5: e347; 10.1038/bcj.2015.75

Abstract | Full Text

Letters to the Editor

Top

Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma

S Ozaki, H Handa, T Saitoh, H Murakami, M Itagaki, H Asaoku, K Suzuki, A Isoda, M Matsumoto, M Sawamura, J Konishi, K Sunami, N Takezako, S Hagiwara, Y Kuroda, T Chou, E Nagura and K Shimizu

Blood Cancer J 2015 5: e349; 10.1038/bcj.2015.79

Full Text

A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

C Papayannidis, D J DeAngelo, W Stock, B Huang, M N Shaik, R Cesari, X Zheng, J M Reynolds, P A English, M Ozeck, J C Aster, F Kuo, D Huang, P D Lira, K R McLachlan, K A Kern, G Garcia-Manero and G Martinelli

Blood Cancer J 2015 5: e350; 10.1038/bcj.2015.80

Full Text

Advertisement
Nature Publishing Group offers a free open access funding support service to enable authors to discover and apply for article processing charge funding available to them.

Visit our website for further advice on the funding options available, and guidance in approaching funders and institutions, or email openaccess@nature.com for more information. 

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: